201 related articles for article (PubMed ID: 23731093)
1. Prazosin reduces alcohol drinking throughout prolonged treatment and blocks the initiation of drinking in rats selectively bred for high alcohol intake.
Froehlich JC; Hausauer BJ; Federoff DL; Fischer SM; Rasmussen DD
Alcohol Clin Exp Res; 2013 Sep; 37(9):1552-60. PubMed ID: 23731093
[TBL] [Abstract][Full Text] [Related]
2. A Combination of Naltrexone + Varenicline Retards the Expression of a Genetic Predisposition Toward High Alcohol Drinking.
Froehlich JC; Fischer SM; Nicholson ER; Dilley JE; Filosa NJ; Smith TN; Rademacher LC
Alcohol Clin Exp Res; 2017 Mar; 41(3):644-652. PubMed ID: 28055135
[TBL] [Abstract][Full Text] [Related]
3. Prazosin + Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in P Rats with a Protracted History of Extensive Voluntary Alcohol Drinking, Dependence, and Multiple Withdrawals.
Rasmussen DD; Kincaid CL; Froehlich JC
Alcohol Clin Exp Res; 2015 Sep; 39(9):1832-41. PubMed ID: 26260061
[TBL] [Abstract][Full Text] [Related]
4. Combining naltrexone and prazosin in a single oral medication decreases alcohol drinking more effectively than does either drug alone.
Froehlich JC; Hausauer BJ; Rasmussen DD
Alcohol Clin Exp Res; 2013 Oct; 37(10):1763-70. PubMed ID: 23875623
[TBL] [Abstract][Full Text] [Related]
5. Prazosin Reduces Alcohol Intake in an Animal Model of Alcohol Relapse.
Froehlich JC; Hausauer B; Fischer S; Wise B; Rasmussen DD
Alcohol Clin Exp Res; 2015 Aug; 39(8):1538-46. PubMed ID: 26207767
[TBL] [Abstract][Full Text] [Related]
6. Combining the α1 -adrenergic receptor antagonist, prazosin, with the β-adrenergic receptor antagonist, propranolol, reduces alcohol drinking more effectively than either drug alone.
Rasmussen DD; Beckwith LE; Kincaid CL; Froehlich JC
Alcohol Clin Exp Res; 2014 Jun; 38(6):1532-9. PubMed ID: 24891220
[TBL] [Abstract][Full Text] [Related]
7. The alpha1-adrenergic receptor antagonist, prazosin, reduces alcohol drinking in alcohol-preferring (P) rats.
Rasmussen DD; Alexander LL; Raskind MA; Froehlich JC
Alcohol Clin Exp Res; 2009 Feb; 33(2):264-72. PubMed ID: 19032582
[TBL] [Abstract][Full Text] [Related]
8. Varenicline Reduces Alcohol Intake During Repeated Cycles of Alcohol Reaccess Following Deprivation in Alcohol-Preferring (P) Rats.
Froehlich JC; Nicholson ER; Dilley JE; Filosa NJ; Rademacher LC; Smith TN
Alcohol Clin Exp Res; 2017 Aug; 41(8):1510-1517. PubMed ID: 28617959
[TBL] [Abstract][Full Text] [Related]
9. Combining Varenicline (Chantix) with Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in a Rodent Model of Alcoholism.
Froehlich JC; Fischer SM; Dilley JE; Nicholson ER; Smith TN; Filosa NJ; Rademacher LC
Alcohol Clin Exp Res; 2016 Sep; 40(9):1961-70. PubMed ID: 27469281
[TBL] [Abstract][Full Text] [Related]
10. Effects of 5-HT(3) receptor antagonists on daily alcohol intake under acquisition, maintenance, and relapse conditions in alcohol-preferring (P) rats.
Rodd-Henricks ZA; McKinzie DL; Edmundson VE; Dagon CL; Murphy JM; McBride WJ; Lumeng L; Li TK
Alcohol; 2000 May; 21(1):73-85. PubMed ID: 10946160
[TBL] [Abstract][Full Text] [Related]
11. The α2-adrenergic receptor agonist, clonidine, reduces alcohol drinking in alcohol-preferring (P) rats.
Rasmussen DD; Alexander L; Malone J; Federoff D; Froehlich JC
Alcohol; 2014 Sep; 48(6):543-9. PubMed ID: 25085719
[TBL] [Abstract][Full Text] [Related]
12. The α1-adrenergic receptor antagonist, doxazosin, reduces alcohol drinking in alcohol-preferring (P) Rats.
O'Neil ML; Beckwith LE; Kincaid CL; Rasmussen DD
Alcohol Clin Exp Res; 2013 Feb; 37(2):202-12. PubMed ID: 22758213
[TBL] [Abstract][Full Text] [Related]
13. Prazosin Prevents Increased Anxiety Behavior That Occurs in Response to Stress During Alcohol Deprivations.
Rasmussen DD; Kincaid CL; Froehlich JC
Alcohol Alcohol; 2017 Jan; 52(1):5-11. PubMed ID: 27797712
[TBL] [Abstract][Full Text] [Related]
14. Naloxone retards the expression of a genetic predisposition toward alcohol drinking.
Badia-Elder NE; Mosemiller AK; Elder RL; Froehlich JC
Psychopharmacology (Berl); 1999 Jun; 144(3):205-12. PubMed ID: 10435386
[TBL] [Abstract][Full Text] [Related]
15. Effects of prazosin, an α1-adrenergic receptor antagonist, on the seeking and intake of alcohol and sucrose in alcohol-preferring (P) rats.
Verplaetse TL; Rasmussen DD; Froehlich JC; Czachowski CL
Alcohol Clin Exp Res; 2012 May; 36(5):881-6. PubMed ID: 21981346
[TBL] [Abstract][Full Text] [Related]
16. Chronic treatment with prazosin or duloxetine lessens concurrent anxiety-like behavior and alcohol intake: evidence of disrupted noradrenergic signaling in anxiety-related alcohol use.
Skelly MJ; Weiner JL
Brain Behav; 2014 Jul; 4(4):468-83. PubMed ID: 25161814
[TBL] [Abstract][Full Text] [Related]
17. Co-Administration of Low-Dose Naltrexone and Bupropion Reduces Alcohol Drinking in Alcohol-Preferring (P) Rats.
Nicholson ER; Dilley JE; Froehlich JC
Alcohol Clin Exp Res; 2018 Mar; 42(3):571-577. PubMed ID: 29222923
[TBL] [Abstract][Full Text] [Related]
18. Effects of short deprivation and re-exposure intervals on the ethanol drinking behavior of selectively bred high alcohol-consuming rats.
Bell RL; Rodd ZA; Schultz JA; Peper CL; Lumeng L; Murphy JM; McBride WJ
Alcohol; 2008 Aug; 42(5):407-16. PubMed ID: 18486429
[TBL] [Abstract][Full Text] [Related]
19. Selective reduction of alcohol drinking in Sardinian alcohol-preferring rats by a sigma-1 receptor antagonist.
Sabino V; Cottone P; Zhao Y; Steardo L; Koob GF; Zorrilla EP
Psychopharmacology (Berl); 2009 Aug; 205(2):327-35. PubMed ID: 19440699
[TBL] [Abstract][Full Text] [Related]
20. Effects of chronic alcohol treatment on acoustic startle reactivity during withdrawal and subsequent alcohol intake in high and low alcohol drinking rats.
Chester JA; Blose AM; Froehlich JC
Alcohol Alcohol; 2005; 40(5):379-87. PubMed ID: 15939705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
